Can Pharma Make a Business Case for Social Media? (2008 Digital Pharma Presentaiton)
by shwen Add commentsIt took me a while to clean up the slides, not so much in terms of the actual content, but more on the visuals, numbers, and attributions. Here’s a list of the major changes from the original presentation:
- Edited images that were blur and/or would not display on PC
- Replaced images that were NOT covered by a Creative Commons license
- Removed embedded videos
- Added some details to MS Academy Mobile case in place of video
- Added resource links and contact details at end of presentation
As you can see, none of the changes significantly affected the main content that was presented, so it’s pretty much the same deck with a few minor adjustments for “public release”. The sections/topics I cover in this presentation are still the following:
- What is Social Media?
- What are the main hurdles?
- Why is it important?
- Where does it fit in?
- How do I get started?
- What strategies can we use?
- How about regulatory concerns?
- What about ROI?
- Final Thoughts
Over the next few weeks, I hope to cover each of the sections in more detail via this blog, so do keep a look out. In the mean time, feel free to send an email or tweet (@shwen) with any questions or leave me a comment about them. Would love to hear your feedback!
Also, if you attended the Digital Pharma conference and/or are thinking about attending Digital Pharma 2009, please send me your thoughts, ideas, feedback on what value and opportunities you would like to experience at this conference. Since I am chairing it next year, I hope to really bring the voice of the participants into the development of the conference program!
NOTE: I have decided to cover the presentaiton under a Creative Commons Attribution and Share Alike license.
November 7th, 2008 at 7:55 am
[...] Gwee has an on-line SlideShare on his recent presentation, “Can Pharma make a Business Case for Social Media?” Shwen’s a smart cookie. Keep a close eye on him if you’re interesting in social [...]
November 7th, 2008 at 8:15 pm
Shwen-
Thank you for posting this. I just wish I could have heard you speak about this.
Mike
November 7th, 2008 at 11:56 pm
Mike,
You are most welcome! Glad to hear that you found it useful. Wish you could have been at the meeting to, but you know my number, so just call me with any questions, bud. Thanks for your comment!
November 10th, 2008 at 11:30 pm
[...] Melissa Davies (Nielsen Analyst and author of the article. Nice blog, too!) does a great job providing an overview of some fundamental issues that pharma struggles with when it comes to Social Media and UGC (user generated content). Chief among those is, of course, the issue of Adverse Event (AE) reporting, which is a key focus of this paper and is nicely called out with some great information. She also goes on to provide many examples on how and where pharma can start with social media; all of which I completely agree with and some which are very similar to the suggestions I made in my presentation on Can Pharma Make a Business Case for Social Media in Pharma. [...]
November 12th, 2008 at 7:29 am
Hey Shwen – Great job on this presentation, and thank you for sharing it here. You’ve put together an excellent roadmap for many people with these slides, and I look forward to seeing the innovation and change ahead for our industry. Speak to you soon. – Andy
November 12th, 2008 at 11:05 am
Andy, Thanks so much for your kind words — I’m glad that people are finding it useful. I too am looking forward to where innovation will take us. More importantly, is how people will use these tools to deliver something that is meaningful and valuable.